Related Experiment Video
Updated: Apr 6, 2026
09:56
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
15.7K
Cyclodextrin-functionalized polymers as drug carriers for cancer therapy
1Key Laboratory of Nonferrous Metals Chemistry and Resources Utilization of Gansu Province, and Department of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, Gansu 730000, China. weih@lzu.edu.cn.
Biomaterials Science
|July 30, 2015
Summary
Cyclodextrin-functionalized polymers offer advanced drug delivery for cancer therapy. This review highlights recent progress in these biomaterials, focusing on their structure, applications, and future potential.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Supramolecular Chemistry
- Nanomedicine
Background:
- Cyclodextrins (CDs) are widely studied cyclic molecules known for their amphiphilicity and inclusion capabilities.
- Integrating CD chemistry with polymer science creates novel biomaterials leveraging host-guest interactions and advanced polymer techniques.
- CD-functionalized polymers are emerging as promising candidates for targeted drug delivery systems.
Purpose of the Study:
- To review recent advancements in cyclodextrin-functionalized polymers for cancer therapy applications.
- To summarize diverse structures of CD-functionalized polymers used as drug carriers.
- To highlight the therapeutic applications and future prospects of these materials in oncology.
Main Methods:
- Review of current literature on cyclodextrin-functionalized polymers.
- Analysis of different polymer architectures incorporating cyclodextrin moieties.
- Evaluation of drug delivery efficacy and cancer therapeutic applications.
Main Results:
- Various CD-functionalized polymer structures have been developed for drug delivery.
- These polymers demonstrate significant potential as effective drug carriers in cancer therapy.
- Integration of host-guest chemistry enhances drug loading and targeted release.
Conclusions:
- CD-functionalized polymers represent a rapidly advancing field with significant promise for cancer drug delivery.
- Further research into novel structures and therapeutic strategies is warranted.
- These biomaterials offer a versatile platform for developing next-generation cancer therapeutics.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
114
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
114
01:24Modified-Release Drug Delivery Systems: Site-Targeted
112
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
112
01:27Drug Delivery Systems: Different Types
258
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
258
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K